The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123859974 12385997 4 F 20151204 20160801 20160519 20160812 EXP US-BAYER-2016-093565 BAYER 34.00 YR A M Y 113.38000 KG 20160812 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123859974 12385997 1 SS XARELTO RIVAROXABAN 1 Oral 20 MG, UNK U UNKNOWN 0 20 MG FILM-COATED TABLET
123859974 12385997 2 SS XARELTO RIVAROXABAN 1 Oral 15 MG, UNK U UNKNOWN 0 15 MG FILM-COATED TABLET
123859974 12385997 3 SS XARELTO RIVAROXABAN 1 U 0 FILM-COATED TABLET
123859974 12385997 4 SS TYVASO TREPROSTINIL 1 Unknown UNK U BXGH8T1A;BXGVGT1;BXH7CK1 0
123859974 12385997 5 SS REMODULIN TREPROSTINIL 1 Unknown UNK U 0
123859974 12385997 6 PS ADEMPAS RIOCIGUAT 1 Oral UNK U BXGH8T1A;BXGVGT1;BXH7CK1 204819 TABLET
123859974 12385997 7 SS ADEMPAS RIOCIGUAT 1 Oral .5 MG, TID U BXGH8T1A;BXGVGT1;BXH7CK1 204819 .5 MG TABLET
123859974 12385997 8 SS ADEMPAS RIOCIGUAT 1 Oral 2 MG, TID U BXGH8T1A;BXGVGT1;BXH7CK1 204819 2 MG TABLET TID
123859974 12385997 9 SS ADEMPAS RIOCIGUAT 1 Oral 2.5 MG, TID U BXGH8T1A;BXGVGT1;BXH7CK1 204819 2.5 MG TABLET TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123859974 12385997 1 Pulmonary embolism
123859974 12385997 2 Deep vein thrombosis
123859974 12385997 3 Embolism venous
123859974 12385997 4 Pulmonary hypertension
123859974 12385997 5 Product used for unknown indication
123859974 12385997 6 Pulmonary arterial hypertension
123859974 12385997 7 Pulmonary hypertension
123859974 12385997 8 Pulmonary arterial hypertension
123859974 12385997 9 Pulmonary arterial hypertension

Outcome of event

Event ID CASEID OUTC COD
123859974 12385997 HO
123859974 12385997 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123859974 12385997 Chest pain
123859974 12385997 Cough
123859974 12385997 Dyspnoea
123859974 12385997 Gastrooesophageal reflux disease
123859974 12385997 Haemoptysis
123859974 12385997 Haemorrhage
123859974 12385997 Hypoxia
123859974 12385997 Thrombectomy
123859974 12385997 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123859974 12385997 1 20140122 20160102 0
123859974 12385997 2 20130528 20140114 0
123859974 12385997 4 20150726 0
123859974 12385997 6 20150728 0